EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calvert Formula Modification for Optimized Carboplatin Dosing in Breast Cancer with Preserved Renal Function

Jihyun Jeon, Jiyeon Jeon iD, Huong Tra Dang iD, Eun-Hyang Choi, Sang Yull Kang, Hwi-Yeol Yun iD, Jung-Woo Chae iD, Jae Hyun Kim iD, Soyoung Lee

Pharmaceutics · 24.03.2026 · 18 (4) · 398

DOI: 10.3390/pharmaceutics18040398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 24.03.2026. Verfasst von Jihyun Jeon und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chungnam National University, the Institute of Information & Communications Technology Planning Evaluation, National Research Foundation of Korea (NRF) grant funded by the Korean government, Korea Environmental Industry & Technology Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Although the Calvert formula has been widely used to guide carboplatin dosing, it may yield inaccurate dose predictions in certain patient populations. We aimed to evaluate the adequacy of the conventional Calvert formula and to propose structural modifications to enhance dosing accuracy in breast cancer patients with preserved renal function (CrCL ≥ 55 mL/min). Methods: A systematic review and meta-analysis were conducted to integrate published pharmacokinetic models in patients with breast cancer. Two retrospective datasets (n = 154) were combined into a single analysis dataset and used to calculate carboplatin doses based on the conventional formulas using creatinine clearance (CrCL) or estimated glomerular filtration rate (eGFR), as well as a modified formula incorporating an additional constant (α). Performance was assessed by the proportion of subjects achieving target area under the curve (AUC) attainment (4–6 mg·min/mL), underexposure (

Schlagwörter

Stichwörter der Autor:innen

Calvert formulabreast cancercarboplatinmeta-analysispopulation pharmacokinetic model

Autor:innen und Institutionen

  • College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • Department of Pharmacy, Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong 18450, Gyeonggi, Republic of Korea.
  • Department of Surgery, Research Institute of Clinical Medicine, Jeonbuk National University Hospital, Jeonju 54907, Jeonbuk-do, Republic of Korea.
  • Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
  • Department of Bio-AI Convergence, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • Senior Health Convergence Research Center, Chungnam National University, Daejeon 34134, Republic of Korea.

ORCID-Profile: Jiyeon Jeon, Huong Tra Dang, Hwi-Yeol Yun, Jung-Woo Chae, Jae Hyun Kim

Förderung

  • Chungnam National University, the Institute of Information & Communications Technology Planning Evaluation
  • National Research Foundation of Korea (NRF) grant funded by the Korean government
  • Korea Environmental Industry & Technology Institute
  • Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea
  • Korea Institute of Toxicology (KIT) Research Program
  • Ministry of Health & Welfare
  • Ministry of Trade, Industry, and Energy
  • Ministry of Food and Drug Safety

Zitieren

APA

Jeon, J., Jeon, J., Dang, H. T., Choi, E. H., Kang, S. Y., Yun, H. Y., Chae, J. W., Kim, J. H., & Lee, S. (2026). Calvert Formula Modification for Optimized Carboplatin Dosing in Breast Cancer with Preserved Renal Function. Pharmaceutics, 18(4), 398. https://doi.org/10.3390/pharmaceutics18040398

Vancouver

Jeon J, Jeon J, Dang HT, Choi EH, Kang SY, Yun HY, et al. Calvert Formula Modification for Optimized Carboplatin Dosing in Breast Cancer with Preserved Renal Function. Pharmaceutics. 2026;18(4):398. doi:10.3390/pharmaceutics18040398

BibTeX
@article{Jeon2026,
  author = {Jeon, Jihyun and Jeon, Jiyeon and Dang, Huong Tra and Choi, Eun-Hyang and Kang, Sang Yull and Yun, Hwi-Yeol and Chae, Jung-Woo and Kim, Jae Hyun and Lee, Soyoung},
  title = {Calvert Formula Modification for Optimized Carboplatin Dosing in Breast Cancer with Preserved Renal Function},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {398},
  doi = {10.3390/pharmaceutics18040398}
}
Kostenlos starten →